(68 days)
Not Found
No
The summary describes a re-design of the x-ray source assembly and mentions standard image processing, but there is no mention of AI or ML capabilities, training data, or performance metrics typically associated with AI/ML devices.
No
Explanation: The device is an angiographic X-ray system used for generating images for diagnostic and interventional procedures, and image-guided surgical procedures. It is an imaging device, not a device that provides therapy.
Yes
The "Intended Use / Indications for Use" section states that the systems are "indicated for use... in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and nonvascular, diagnostic and interventional procedures." This explicitly mentions diagnostic procedures.
No
The device description clearly outlines a complex hardware system including a C-arm positioner, x-ray table, x-ray tube assembly, power unit, and digital detector, in addition to an image processing unit. While software is involved in image processing and system control, the device is fundamentally a hardware-based X-ray system.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The description clearly states that this device is an angiographic X-ray system used to generate fluoroscopic and rotational images of human anatomy. It directly interacts with the patient's body using X-rays to create images.
- Intended Use: The intended use is for generating images for diagnostic and interventional procedures, as well as image-guided surgical procedures. This involves imaging the internal structures of the body, not analyzing samples taken from the body.
The device is an imaging system that works in vivo (within the living body), not in vitro (in glass or outside the body).
N/A
Intended Use / Indications for Use
The angiographic X-Ray systems are indicated for use for patients from newborn to generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular, diagnostic and interventional procedures.
Additionally, with the OR Table, the angiographic X-Ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image-guided surgical procedures.
The OR Table is suitable for interventional and surgical procedures.
Product codes (comma separated list FDA assigned to the subject device)
OWB, JAA, IZI, OXO
Device Description
GE HealthCare IGS interventional x-ray systems are designed to perform monoplane fluoroscopic x-ray examinations to provide the imaging information needed to perform minimally invasive interventional X-Ray imaging procedures (standard configuration).
Additionally, in the OR configuration (with an OR Table), these systems allow to perform surgery and X-Ray image guided surgical procedures in a hybrid Operating Room.
Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR are monoplane GE HealthCare IGS interventional X-Ray system product models. Each product model is designed with a set of components that are combined into different configurations for providing specialized interventional x-ray systems. GE HealthCare IGS interventional x-ray system consists of a C-arm positioner, an x-ray table or the interface to the radiologic table, an x-ray tube assembly, an x-ray power unit with its exposure control unit, an x-ray imaging chain (including a digital detector and an image processing unit).
Allia IGS 5 is a monoplane system (C-arm positioner with L-shaped gantry) and is proposed in IGS 530 configuration with a square digital detector of 31cm (also called 30 cm configuration) or in IGS 520 configuration with a square digital detector of 20.5cm (also called 20 cm configuration). These product configurations are available in Standard configuration with Omega V table or Omega IV table (IGS 520 configuration only); or in OR configuration with Innova-IQ GE HealthCare OR table.
Allia IGS 3 is a monoplane system (C-arm positioner with L-shaped gantry) and is proposed with a square digital detector of 31cm. This product is available in Standard configuration with Omega V table. Allia IGS 7 is a monoplane system (C-arm with mobile AGV gantry) and is proposed in IGS 730 configuration with a square 31cm digital detector (also called 30 cm configuration). This product configuration is described in sub configurations: Standard or OR configuration. The Innova-IQ table in the OR configuration is the GE HealthCare OR table. Allia IGS 7 OR is a monoplane system (C-arm positioner with mobile AGV gantry) and is proposed in IGS 730 OR configuration with a square 31cm digital detector configuration. This is the product model compatible with a qualified configuration of the Maquet Magnus OR table system. This product model is provided with a table integration kit. The Magnus OR table configuration compatible with Allia IGS 7 OR includes flat table top configurations for Interventional X-Ray imaging and surgery procedures, an optional universal table top (table top with articulated joints) to enable expansion to surgical procedures requiring advanced patient positioning and with X-Ray imaging capabilities. A set of Magnus OR table accessories is included in the compatible configuration.
The purpose of this Premarket Notification is for the re-design of the x-ray source assembly.
Allia IGS 3, Allia IGS 5 in IGS 520 and IGS 530 configurations, Allia IGS 7 in IGS 730 configuration, and Allia IGS 7 OR in IGS 730 OR configuration will be improved and will be marketed as Allia IGS 3 Pulse, Allia IGS 5 Pulse, Allia IGS 7 Pulse, and Allia IGS 7 OR Pulse. All these four models may also be designated with the marketing name Allia IGS Pulse.
Mentions image processing
Yes, "image processing unit"
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
Human anatomy
Indicated Patient Age Range
Newborn to geriatric
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing:
The verification and validation testing have been successfully completed as required by design control procedures under GE HealthCare's quality system. This includes risk management, software verification and validation testing as well as image quality and dose performance using standard IQ metrics and QA phantoms.
Additional engineering bench testing was performed to substantiate the quantitative performance claims related to the new x-ray source assembly.
Additionally, testing was performed to demonstrate the overall imaging performance of Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR systems using a wide variety of anthropomorphic phantoms.
Clinical Testing:
The Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR systems can be fully tested on the engineering bench thus no additional clinical testing was required to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1650 Image-intensified fluoroscopic x-ray system.
(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
October 11, 2023
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square, the words "U.S. FOOD & DRUG ADMINISTRATION" are written in blue.
GE Medical Systems SCS % Hubert Welsch Associate Regulatory Affairs Program Manager 283 Rue De La Miniere Buc, 78530 FRANCE
Re: K232344
Trade/Device Name: Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: Class II Product Code: OWB, JAA, IZI and OXO Dated: September 14, 2023 Received: September 15, 2023
Dear Hubert Welsch:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerelv.
Lu Jiang
Lu Jiang, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K232344
Device Name
Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR
Indications for Use (Describe)
The angiographic X-Ray systems are indicated for use for patients from newborn to generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular, diagnostic and interventional procedures.
Additionally, with the OR Table, the angiographic X-Ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image-guided surgical procedures.
The OR Table is suitable for interventional and surgical procedures.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for GE HealthCare. The logo consists of the GE monogram in a circle on the left, followed by the words "GE HealthCare" in a sans-serif font. The logo is purple in color and is set against a white background.
510(k) Summary
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date: | 27-September-2023 |
|---|---|
| Submitter: | GE MEDICAL SYSTEMS SCS |
| 283 RUE DE LA MINIERE | |
| 78530 BUC, FRANCE | |
| Primary Contact | |
| Person: | Hubert WELSCH |
| Associate Regulatory Affairs Program Manager | |
| GE HealthCare (GE MEDICAL SYSTEMS SCS) | |
| Tel: (+33)-1-3070-3847 | |
| Email: hubert.welsch@ge.com | |
| Secondary Contact | |
| Person: | Michelle HUETTNER |
| Regulatory Affairs Director IGT and Oncology | |
| GE HealthCare | |
| Tel: +1 (901) 558-8035 | |
| Email: michelle.huettner@ge.com | |
| Device Trade Name: | Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR |
| Common/Usual | |
| Name: | Interventional fluoroscopic x-ray system, angiographic x-ray system |
| Regulation | |
| Description: | Image-intensified fluoroscopic x-ray system |
| Regulation Number: | 21 CFR 892.1650 |
| Product Code: | OWB |
| Subsequent Product | |
| Codes | JAA, IZI; and OXO for Allia IGS 7 and Allia IGS 7 OR. |
| Classification: | Class II |
4
Image /page/4/Picture/0 description: The image shows the logo for GE HealthCare. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is purple and features a stylized design. The text is also purple and is written in a clean, sans-serif font.
| Predicate Device(s): | K181403: Innova IGS 5, Discovery IGS 7, Discovery IGS 7 OR |
|---|---|
| Common/Usual Name: Interventional fluoroscopic x-ray system, | |
| angiographic x-ray system | |
| Regulation description: Image-intensified fluoroscopic x-ray system | |
| Regulation Number: 21 CFR 892.1650 | |
| Product Code: OWB | |
| Subsequent Product Codes: JAA, IZI; and OXO for Discovery IGS 7 and 7 OR | |
5
Image /page/5/Picture/0 description: The image shows the GE Healthcare logo. The logo consists of a purple circular emblem with a stylized "GE" monogram inside. To the right of the emblem, the text "GE HealthCare" is written in a simple, sans-serif font, also in purple.
| Device Description: | GE HealthCare IGS interventional x-ray systems are designed to perform monoplane fluoroscopic x-ray examinations to provide the imaging information needed to perform minimally invasive interventional X-Ray imaging procedures (standard configuration).
Additionally, in the OR configuration (with an OR Table), these systems allow to perform surgery and X-Ray image guided surgical procedures in a hybrid Operating Room.
Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR are monoplane GE HealthCare IGS interventional X-Ray system product models. Each product model is designed with a set of components that are combined into different configurations for providing specialized interventional x-ray systems. GE HealthCare IGS interventional x-ray system consists of a C-arm positioner, an x-ray table or the interface to the radiologic table, an x-ray tube assembly, an x-ray power unit with its exposure control unit, an x-ray imaging chain (including a digital detector and an image processing unit).
Allia IGS 5 is a monoplane system (C-arm positioner with L-shaped gantry) and is proposed in IGS 530 configuration with a square digital detector of 31cm (also called 30 cm configuration) or in IGS 520 configuration with a square digital detector of 20.5cm (also called 20 cm configuration). These product configurations are available in Standard configuration with Omega V table or Omega IV table (IGS 520 configuration only); or in OR configuration with Innova-IQ GE HealthCare OR table.
Allia IGS 3 is a monoplane system (C-arm positioner with L-shaped gantry) and is proposed with a square digital detector of 31cm. This product is available in Standard configuration with Omega V table. Allia IGS 7 is a monoplane system (C-arm with mobile AGV gantry) and is proposed in IGS 730 configuration with a square 31cm digital detector (also called 30 cm configuration). This product configuration is described in sub configurations: Standard or OR configuration. The Innova-IQ table in the OR configuration is the GE HealthCare OR table. Allia IGS 7 OR is a monoplane system (C-arm positioner with mobile AGV gantry) and is proposed in IGS 730 OR configuration with a square 31cm digital detector configuration. This is the product model compatible with a qualified configuration of the Maquet Magnus OR |
|----------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | |
| | table system. This product model is provided with a table integration kit. The Magnus OR table configuration compatible with Allia IGS 7 OR includes flat table top configurations for Interventional X-Ray imaging and surgery procedures, an optional universal table top (table top with articulated joints) to enable expansion to surgical procedures requiring advanced patient positioning and with X-Ray imaging capabilities. A set of Magnus OR table accessories is included in the compatible configuration.
The purpose of this Premarket Notification is for the re-design of the x-ray source assembly.
Allia IGS 3, Allia IGS 5 in IGS 520 and IGS 530 configurations, Allia IGS 7 |
| | in IGS 730 configuration, and Allia IGS 7 OR in IGS 730 OR configuration will be improved and will be marketed as Allia IGS 3 Pulse, Allia IGS 5 Pulse, Allia IGS 7 Pulse, and Allia IGS 7 OR Pulse. All these four models may also be designated with the marketing name Allia IGS Pulse. |
| Intended Use /
Indications for use: | The angiographic X-ray systems are indicated for use for patients from newborn to geriatric in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and nonvascular, diagnostic and interventional procedures.
Additionally, with the OR table, the angiographic X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image-guided surgical procedures. |
| | The OR table is suitable for interventional and surgical procedures.
The intended use and indications for use are unchanged from the predicate device. |
6
Image /page/6/Picture/0 description: The image shows the GE HealthCare logo. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is purple and contains a stylized design. The text is also purple and is written in a clear, sans-serif font.
7
Image /page/7/Picture/0 description: The image shows the GE Healthcare logo. The logo consists of the GE monogram in a circle on the left, followed by the text "GE HealthCare" in a purple sans-serif font. The logo is simple and modern, and it is easily recognizable.
| Subsystem | Innova IGS 5, in IGS 520 and IGS 530 configurations
Discovery IGS 7 in IGS 730 configuration
Discovery IGS 7 OR in IGS 730 OR configuration
(Predicate Devices, K181403) | Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR (Proposed Devices) | |
|-------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|
| x-ray tube | Performix 160A
- Bi-filament cathode
- 0.3, 0.6, 1.0 focal spot sizes
- Ball bearing | Performix Pulsar
- Tri-filament cathode
- 0.3, 0.5, 0.8 focal spot sizes
- Liquid Metal rotor bearing | |
| Tube cooling unit | Closed-loop remote water chiller | Closed-loop remote oil cooler | |
| High-voltage generator | Jedi 100 VASC 1T
Peak power: 100 kW | Gaia
Peak power: 100 kW | |
| Collimation | CARD AMP
20 cm config
2 pairs of collimation blades.
0.1, 0.2, 0.3, 0.6 and 0.9 mm of copper Spectral filtration.
1 integrated contour filter blades. | AF DSA 01
30 cm config
2 pairs of collimation blades.
0.1, 0.2, 0.3 mm of copper Spectral filtration.
3 integrated contour filter blades. | MFD
2 pairs of collimation blades.
0.1, 0.2, 0.3, 0.6 and 0.9 mm of copper Spectral filtration
1 integrated contour filter blades. |
| | | | |
| | Solid state
digital
detector | -Model NGB20 in 20cm
Configuration
-Model Dynamic 31 in 30cm
Configuration, accompanied
by a detector conditioner
and removable anti-scatter
grids | No change. Identical. |
| | Standards | IEC 60601-1 Ed. 3.0 | IEC 60601-1 Ed. 3.1 |
| | | IEC 60601-1-2 Ed 4.0 | IEC 60601-1-2 Ed 4.0 |
| | | IEC 60601-1-3 Ed 2.0 | IEC 60601-1-3 Ed 2.1 |
| | | IEC 60601-2-28 Ed 2.0 | IEC 60601-2-28 Ed 3.0 |
| | | IEC 60601-2-43 Ed. 2.0 | IEC 60601-2-43 Ed. 2.2 |
| | | NEMA XR-27 | NEMA XR-27 |
| Determination
of Substantial
Equivalence: | The changes described above do not change the fundamental control
mechanism, operating principle, energy type, and do not change the intended
use from the predicate devices. | | |
| | The Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR has completed testing and
is in compliance with IEC60601-1 Ed. 3.1 (FDA Recognition #19-4) and its
associated collateral and particular standards, 21 CFR Subchapter J, and
NEMA standard XR-27. The devices have successfully completed all applicable
testing underthe GE HealthCare quality system and design control. They were
designed and are manufactured under the Quality System Regulations of 21
CFR 820 and ISO 13485. The following quality assurance measures were
applied to the development of the system: | | |
| | • Risk Analysis | | |
| | • Required Reviews | | |
| | • Design Reviews | | |
| | • Testing on unit level (Module verification) | | |
| | • Integration testing (System verification) | | |
| | • Performance testing (Verification) | | |
| | • Safety testing (Verification) | | |
| | • Simulated use testing (Validation) | | |
| | The following FDA guidance documents were utilized in the development of
the devices: | | |
| | • Electromagnetic Compatibility (EMC) of Medical Devices (06-Jun-2022) | | |
| | • Off-The-Shelf Software Use in Medical Devices (FDA, 27-Sep-2019) | | |
| | • Cybersecurity for Networked Medical Devices Containing Off-the-Shelf
(OTS) Software (14-Jan-2005) | | |
| | • Content of Premarket Submissions for Management of Cybersecurity in
Medical Devices (02-Oct-2014) | | |
8
Image /page/8/Picture/0 description: The image contains the logo for GE Healthcare. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is purple and features a stylized design. The text is also purple and uses a sans-serif font.
9
Image /page/9/Picture/0 description: The image shows the GE HealthCare logo. The logo consists of a purple circular emblem with a stylized "GE" inside, followed by the text "GE HealthCare" in purple. The text is aligned to the right of the emblem.
| | Guidance for the Content of Premarket Submissions for Software
Contained in Medical Devices (11-May-2005) Policy Clarification for Certain Fluoroscopic Equipment Requirements
(FDA, 08-May-2019) Pediatric Information for X-ray Imaging Device Premarket Notifications
(28-Nov-2017) GE HealthCare believes the Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR
systems are of comparable type and substantially equivalent to the cleared
predicate systems Innova IGS 5, Discovery IGS 7, Discovery IGS 7 OR
(K181403).
The substantial equivalence was also based on software documentation for a
"Moderate" level of concern device.
Summary of Additional Testing:
Non-Clinical Testing:
The verification and validation testing have been successfully completed as
required by design control procedures under GE HealthCare's quality system.
This includes risk management, software verification and validation testing as
well as image quality and dose performance using standard IQ metrics and QA
phantoms.
Additional engineering bench testing was performed to substantiate the
quantitative performance claims related to the new x-ray source assembly.
Additionally, testing was performed to demonstrate the overall imaging
performance of Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR systems using a
wide variety of anthropomorphic phantoms.
Clinical Testing:
The Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR systems can be fully tested
on the engineering bench thus no additional clinical testing was required to
support substantial equivalence. |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Conclusion: | Based on the conformance to standards, development under the GE
HealthCare quality system, and the engineering testing provided, GE
HealthCare believes that the Allia IGS 3, Allia IGS 5, Allia IGS 7, Allia IGS 7 OR are
as safe and effective, and perform in a substantially equivalent manner to
the predicate devices Innova IGS 5, Discovery IGS 7, Discovery IGS 7
OR (K181403). |